Recode Ventures

Recode Ventures is a venture firm with website and LinkedIn presence whose naming suggests a thesis around technology-driven transformation or ‘recoding’ legacy industries, though the source data carries no disclosed healthcare thesis, sub-vertical focus, AI angle, stage preference, geography or check size. Founders should treat Recode as a generalist early-stage candidate where domain depth in healthcare cannot be assumed. Plausible check sizes for a firm of this profile sit in the $250K to $1.5M range as a participant in seed and Series A rounds, with limited capacity to lead competitive rounds at scale. Recode is most plausibly a fit for digital health, healthcare IT, B2B SaaS targeting healthcare buyers, AI-enabled healthcare workflow tools and adjacent technology-driven healthcare businesses where general venture pattern-matching applies and the founder owns the regulatory and reimbursement narrative. Therapeutics, regulated devices, diagnostics and capital-intensive healthcare plays are unlikely strong fits. Healthcare AI founders pitching Recode should be ready to lead conversations on data strategy, FDA pathway if relevant, and realistic enterprise sales cycles into hospitals and payers. The realistic entry path is direct LinkedIn outreach to firm principals, ideally warmed by a portfolio founder or mutual investor, with a pitch leading on team, traction velocity and capital efficiency. In a first conversation, founders should push for fund size, average check, lead capacity, healthcare exposure in the existing portfolio, named partner conviction and decision timeline before investing meaningful diligence cycles.